Under construction – not a live service
Sign in
Not yet taking people in GermanyNo phase

Exercise Therapy and Bone Consultation for Multiple Myeloma Patients

Tests orthopedic consultation and exercise plans in adults with multiple myeloma bone lesions.

Plain-language title generated from the registry record
Registry title: Exercise Therapy for Multiple Myeloma Patients

Key facts

Where
Heidelberg, GermanySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT07388147, who can take part

Where in Germany

  • Heidelberg University Hospital - GMMG Study GroupHeidelberg, GermanyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital Heidelberg
Trial code
NCT07388147
Record updated
4 February 2026
Original description
Physical exercise is an important supportive therapy for cancer patients, as it improves quality of life in general and might mitigate the side effects of drug treatment. For patients with multiple myeloma in particular, significantly less evidence on the effectiveness of exercise therapy is available due to the fact that this disease is associated with severe bone degradation which might affect bone stability. Advances in oncologic drug treatment have improved overall survival in multiple myeloma significantly. Therefore, there is an increased interest for recommendations on physical activity in this patient group. Due to uncertainties regarding safety and feasibility of exercise therapy in multiple myeloma, both patients and therapists often remain hesitant. Therefore, an orthopaedic outpatient clinic has been established at the Myeloma Center of Heidelberg University Hospital. Here, patients receive consultation on bone stability and individualized physical exercise plans. Based on the expertise gained at the orthopaedic outpatient clinic, the aim of this study is to establish and evaluate structural measures for improved rehabilitation in multiple myeloma and to integrate them into routine clinical care.Read full original descriptionShow less

Structural Measures for Multiple Myeloma Patients to Improve Rehabilitation by Exercise Therapy

Physical exercise is an important supportive therapy for cancer patients, as it improves quality of life in general and might mitigate the side effects of drug treatment. For patients with multiple myeloma in particular, significantly less evidence on the effectiveness of exercise therapy is available due to the fact that this disease is associated with severe bone degradation which might affect bone stability. Advances in oncologic drug treatment have improved overall survival in multiple myeloma significantly. Therefore, there is an increased interest for recommendations on physical activity in this patient group. Due to uncertainties regarding safety and feasibility of exercise therapy in multiple myeloma, both patients and therapists often remain hesitant. Therefore, an orthopaedic outpatient clinic has been established at the Myeloma Center of Heidelberg University Hospital. Here, patients receive consultation on bone stability and individualized physical exercise plans. Based on the expertise gained at the orthopaedic outpatient clinic, the aim of this study is to establish and evaluate structural measures for improved rehabilitation in multiple myeloma and to integrate them into routine clinical care.

Inclusion: newly diagnosed multiple myeloma; Survival prognosis > 6 months; ECOG status ≤ 3; Age ≥18 years; Patients who state that they want to carry out the training program at least 2 x/week and participate in the planned follow-up visits; Ability to give informed consent; Written consent to participate in the study; Sufficient knowledge of written and spoken German.

Exclusion: physical or mental limitation that would prevent participation in the training program or the planned follow-up visits.

ClinicalTrials.gov NCT07388147